Delayed Gadolinium Leakage in Ocular Structures on Brain MR Imaging: Prevalence and Associated Factors

References

1. 1.↵
   1. Hitomi E,
   2. Simpkins AN,
   3. Luby M, et al

   . Blood-ocular barrier disruption in patients with acute stroke. Neurology 2018;90:e915–23 doi:10.1212/WNL.0000000000005123 pmid:29438039

   CrossRefPubMed
2. 2.↵
   1. Förster A,
   2. Al-Zghloul M,
   3. Wenz H, et al

   . Gadolinium leakage in ocular structures is common in lacunar infarction. Stroke 2019;50:193–95 doi:10.1161/STROKEAHA.118.023573 pmid:30580698

   CrossRefPubMed
3. 3.↵
   1. Förster A,
   2. Ramos A,
   3. Wenz H, et al

   . GLOS and HARM in patients with transient neurovascular symptoms with and without ischemic infarction. J Neuroradiol 2022;49:244–49 doi:10.1016/j.neurad.2021.03.007 pmid:33836217

   CrossRefPubMed
4. 4.↵
   1. Förster A,
   2. Wenz H,
   3. Böhme J, et al

   . Asymmetrical gadolinium leakage in ocular structures in stroke due to internal carotid artery stenosis or occlusion. Clin Neuroradiol 2020;30:221–28 doi:10.1007/s00062-018-0754-5 pmid:30593604

   CrossRefPubMed
5. 5.↵
   1. Galmiche C,
   2. Moal B,
   3. Marnat G, et al

   . Delayed gadolinium leakage in ocular structures: a potential marker for age- and vascular risk factor-related small vessel disease? Invest Radiol 2021;56:425–32 doi:10.1097/RLI.0000000000000757 pmid:33481460

   CrossRefPubMed
6. 6.↵
   1. Förster A,
   2. Wenz H,
   3. Böhme J, et al

   . Gadolinium leakage in ocular structures: a novel MRI finding in transient global amnesia. J Neurol Sci 2019;404:63–65 doi:10.1016/j.jns.2019.07.004 pmid:31330456

   CrossRefPubMed
7. 7.↵
   1. Ozkan E,
   2. Gocmen R,
   3. Topcuoglu MA, et al

   . Blood–retina-barrier disruption accompanying blood–brain-barrier dysfunction in posterior reversible encephalopathy syndrome. J Neurol Sci 2014;346:315–17 doi:10.1016/j.jns.2014.08.035 pmid:25218416

   CrossRefPubMed
8. 8.↵
   1. Manfré L,
   2. Midiri M,
   3. Giuffré G, et al

   . Blood-ocular barrier damage: use of contrast-enhanced MRI. Eur Radiol 1997;7:110–14 doi:10.1007/s003300050121 pmid:9000410

   CrossRefPubMed
9. 9.↵
   1. Herrera DA,
   2. Franco S,
   3. Bustamante S, et al

   . Contrast-enhanced T2-FLAIR MR imaging in patients with uveitis. Int Ophthalmol 2017;37:507–12 doi:10.1007/s10792-016-0289-1 pmid:27405314

   CrossRefPubMed
10. 10.↵
    1. Manava P,
    2. Eckrich C,
    3. Luciani F, et al

    . Glymphatic system in ocular diseases: evaluation of MRI findings. AJNR Am J Neuroradiol 2022;43:1012–17 doi:10.3174/ajnr.A7552 pmid:35772805

    Abstract/FREE Full Text
11. 11.↵
    1. Hamel J,
    2. Fiebach JB,
    3. Villringer K

    . Ocular hyperintense acute reperfusion marker. Neurology 2012;79:1622–23 doi:10.1212/WNL.0b013e31826e2662 pmid:23019263

    FREE Full Text
12. 12.↵
    1. Förster A,
    2. Böhme J,
    3. Groden C, et al

    . Gadolinium leakage in ocular structures in optic neuritis. J Clin Neurosci 2019;68:268–70 doi:10.1016/j.jocn.2019.05.050 pmid:31204221

    CrossRefPubMed
13. 13.↵
    1. Deike-Hofmann K,
    2. von Lampe P,
    3. Schlemmer HP, et al

    . The anterior eye chamber: entry of the natural excretion pathway of gadolinium contrast agents? Eur Radiol 2020;30:4633–40 doi:10.1007/s00330-020-06762-4 pmid:32179994

    CrossRefPubMed
14. 14.↵
    1. Deike-Hofmann K,
    2. Reuter J,
    3. Haase R, et al

    . Glymphatic pathway of gadolinium-based contrast agents through the brain. Invest Radiol 2019;54:229–37 doi:10.1097/RLI.0000000000000533 pmid:30480554

    CrossRefPubMed
15. 15.↵
    1. Deng W,
    2. Liu C,
    3. Parra C, et al

    . Quantitative imaging of the clearance systems in the eye and the brain. Quant Imaging Med Surg 2020;10:1–14 doi:10.21037/qims.2019.11.18 pmid:31956524

    CrossRefPubMed
16. 16.↵
    1. Förster A,
    2. Groden C,
    3. Alonso A

    . Response by Förster et al to letter regarding article, “Gadolinium Leakage in Ocular Structures Is Common in Lacunar Infarction.” Stroke 2019;50:e115 doi:10.1161/STROKEAHA.119.024701 pmid:30869567

    CrossRefPubMed
17. 17.↵
    1. Harvey HB,
    2. Gowda V,
    3. Cheng G

    . Gadolinium deposition disease: a new risk management threat. J Am Coll Radiol 2020;17:546–50 doi:10.1016/j.jacr.2019.11.009 pmid:31805251

    CrossRefPubMed
18. 18.↵
    1. Boehm IB

    . Gadolinium deposition disease (GDD): does the missing link exist—a suggested pathologic model. Eur J Intern Med 2022;105:118–20 doi:10.1016/j.ejim.2022.07.008 pmid:35864076

    CrossRefPubMed
19. 19.↵
    1. Coca-Prados M

    . The blood-aqueous barrier in health and disease. J Glaucoma 2014;23:S36–38 doi:10.1097/IJG.0000000000000107 pmid:25275903

    CrossRefPubMed
20. 20.↵
    1. Cunha-Vaz J,
    2. Bernardes R,
    3. Lobo C

    . Blood-retinal barrier. Eur J Ophthalmol 2011;21(Suppl 6):S3–9 doi:10.5301/EJO.2010.6049 pmid:23264323

    CrossRefPubMed
21. 21.↵
    1. Delgado C,
    2. Baweja M,
    3. Crews DC, et al

    . A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease. Am J Kidney Dis 2022;79:268–88.e1 doi:10.1053/j.ajkd.2021.08.003 pmid:34563581

    CrossRefPubMed
22. 22.↵
    1. Kanamalla US,
    2. Boyko OB

    . Gadolinium diffusion into orbital vitreous and aqueous humor, perivascular space, and ventricles in patients with chronic renal disease. AJR Am J Roentgenol 2002;179:1350–52 doi:10.2214/ajr.179.5.1791350 pmid:12388535

    CrossRefPubMed
23. 23.↵
    1. Mathews VP,
    2. Caldemeyer KS,
    3. Lowe MJ, et al

    . Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology 1999;211:257–63 doi:10.1148/radiology.211.1.r99mr25257 pmid:10189481

    CrossRefPubMed
24. 24.↵
    1. Schauersberger J,
    2. Kruger A,
    3. Müllner-Eidenböck A, et al

    . Long-term disorders of the blood-aqueous barrier after small-incision cataract surgery. Eye (Lond) 2000;14(Pt 1):61–63 doi:10.1038/eye.2000.13 pmid:10755102

    CrossRefPubMed
25. 25.↵
    1. Miyake K

    . Blood-retinal barrier in long-standing aphakic eyes after extra- and intracapsular lens extractions. Graefes Arch Clin Exp Ophthalmol 1985;222:232–33 doi:10.1007/BF02133685

    CrossRef